✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Neuropathic PainPain ManagementCannabinoidsChronic PainEvidence Review Why This MattersNeuropathic pain affects millions of patients...
Cannabinoids in Children: Clinical Evidence Review
Clinical Takeaway Clinical evidence on cannabinoid use in children spans 276 studies across interventional, observational, and survey designs, reflecting a growing but still evolving body of research. The living systematic review format...
Cannabinoids, Autophagy, and Alzheimer’s Disease, What This Review Explores and What It Still Leaves Unproven
This 2026 review explores how cannabinoids might influence autophagy pathways relevant to Alzheimer’s disease. Its value is mainly mechanistic and hypothesis-building, with some discussion of early clinical and preclinical signals. It does not prove that cannabinoids currently offer established disease-modifying treatment for Alzheimer’s disease.
CBN launches supervisory pilot to tackle virtual asset risks – Businessday NG
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical CommunicationCannabinoidsClinical DocumentationPatient EducationTerminology Why This MattersThis appears to be about Nigeria's Central Bank...
A component in cannabis can effectively reverse signs of fatty liver disease. Scientists have …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic HepatologyNafldCannabinoidsMetabolismResearch Why This MattersFatty liver disease affects over 100 million Americans and lacks effective...
Cannabis Pharmacokinetics Review: THC, CBD, Dosing
This paper is a broad evidence review of human pharmacokinetic studies on THC and CBD. It helps clarify how route, formulation, food, sex, drug interactions, and patient factors can meaningfully change absorption and exposure. Its main limitation is that it synthesizes heterogeneous studies rather than providing one unified, practice-ready dosing framework.
Flipping the Switch to LED Grow Lights: Adjustments and Refinements
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Product QualityCultivationCannabinoidsTerpenesConsistency Why This MattersLED cultivation technology can influence cannabinoid and terpene profiles in...
CBN using automation to drive expansion, anti-money laundering across financial ecosystem
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical CannabisCannabinoidsClinical ErrorAcronym Confusion Why This MattersThis appears to be a financial/banking article about...
Can Cannabis Replace Opioids for Chronic Pain? A New Review Maps What We Know—and What Remains Uncertain
Clinical evidence has shown that cannabinoids can significantly reduce the intensity of chronic pain, particularly in cases of neuropathy, multiple sclerosis, arthritis, and other painful conditions that are unresponsive to conventional treatments. However, the full integration of medical cannabis into clinical practice faces significant obstacles, including the need for standardized dosing, long-term safety data, and regulatory frameworks.
Cannabis for Postoperative Pain: Too Little Evidence to Know
Due to the heterogeneity of methods, it was not possible to carry out meta-analytic evaluations and only qualitative evaluations were feasible.